RT Journal
A1 Arevalo J, Arias JD, Serrano MA
T1 ORal propranolol for exudative retinal detachment in diffuse choroidal hemangioma
JF Archives of Ophthalmology
JO Archives of Ophthalmology
YR 2011
FD October 1
VO 129
IS 10
SP 1373
OP 1375
DO 10.1001/archophthalmol.2011.294
UL http://dx.doi.org/10.1001/archophthalmol.2011.294
AB 
The main abnormality of the uveal tract in patients with Sturge-Weber syndrome is diffuse choroidal hemangioma (DCH). Diffuse choroidal hemangioma can lead to a total retinal detachment and secondary neovascular glaucoma. Radiotherapy and photodynamic therapy are currently the preferred methods of treatment. Low-dose lens-sparing radiotherapy or proton beam irradiation can induce tumor regression and resolution of subretinal fluid.1 Short-term treatment success using photodynamic therapy has also been reported.2